Veness Adam M has filed 4 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 100000 shares of Dianthus Therapeutics, Inc. /DE/ ($DNTH) on February 03, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 3, 2026 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Veness Adam M | SVP, General Counsel and Sec. | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 42,876,015 | 9999.99% | 0.23% |
| Feb. 3, 2025 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Veness Adam M | SVP, General Counsel and Sec. | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2024 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Veness Adam M | SVP, General Counsel and Sec. | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2024 | Dianthus Therapeutics, Inc. /DE/ | $DNTH | Veness Adam M | SVP, General Counsel and Sec. | A | Stock Option (Right to Buy) | 110000 | $0.00 | 110,000.0000 | 0 | 9999.99% | 0.00% |